News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments
Photo of Tom Powles taken from bartscancer.london
May 24, 2024, 00:08

Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments

Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:

“The ESMO guidlines make a clear distinction between papillary and other ‘non-clear cell’ renal cancers. Mixing these together has hampered new treatments. Sarcomatoid needs upfront PD1 combos. Other subgroups (chromaphobe etc) need more data.”

Tom Powles: Mixing papillary and other ‘non-clear cell’ renal cancers guidlines has hampered new treatments

Further information.
Source: Tom Powles/X

cancer ESMO non-clear cell renal cancers OncoDaily Oncology Sarcomatoid Tom Powles
Special Coverage
Insight
Nov 3, 2024, 17:46
Rana McKay: Evaluating ACP1 expression in prostrate cancer
Insight
Nov 3, 2024, 17:23
Talha Badar: A predictive model for therapy failure in patients with CML receiving TKI therapy
Insight
Nov 3, 2024, 17:05
Vincent Rajkumar: Survival improvement in patients with HIV associated B cell lymphoma that adopted the Medicaid expansion of ACA
Blog
Nov 3, 2024, 16:51
Addressing cancer disparities among Black women - American Cancer Society
Blog
Nov 3, 2024, 16:48
Mohit Manrao: Discussing cancer innovation and biomarkers at the STAT Summit
Blog
Nov 3, 2024, 16:46
Lindsey Gasparini: New FDA-approved therapy targets Claudin18.2 in gastric cancers
Blog
Nov 3, 2024, 16:45
Nermean Mostafa: Launching a new oncology training platform in Egypt
Blog
Nov 3, 2024, 16:35
Jasmine Kamboj: Honored to be on the ballot for the Designated Community Oncology seat
Blog
Nov 3, 2024, 16:34
Crystal Denlinger: Our biannual guidelines harmonization update meeting
Blog
Nov 3, 2024, 16:30
Yale University's $150M investment into AI leadership is equipping medstudents with the tools to tackle tomorrow's healthcare challenges
Insight
Nov 3, 2024, 16:27
Alessandro Di Federico: EFS in patients with resectable NSCLC treated with neoadjuvant Chemo-IO
Blog
Nov 3, 2024, 16:25
Raising awareness on biomarker information gaps for metastatic breast cancer patients - ABC Global Alliance